(Q79226753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

placebo-controlled trial

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Hans Nissbrandt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Christer Allgulander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Karin Sörvik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Christina Ysander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Elias Eriksson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

11 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

153-161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301216

20 December 2019

exact match

0 references

cites work

The epidemiology of perimenstrual psychological symptoms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Sertraline in stroke-associated lability of mood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Effect of clomipramine on premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

How does premenstrual dysphoric disorder relate to depression and anxiety disorders?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Paroxetine versus citalopram treatment of pathological crying after brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

The measurement of disability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Fluoxetine as a treatment for emotional lability after brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Selective serotonin reuptake inhibitors for premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301216

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17035933%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 December 2019

1051303149

0 references

Fatcat ID

release_llhajnd57bf2jj6lvqpduyonhq

0 references

1 reference